112 related articles for article (PubMed ID: 27913051)
21. Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma.
Sahin AA; Myhre M; Ro JY; Sneige N; Dekmezian RH; Ayala AG
Acta Cytol; 1991; 35(3):277-80. PubMed ID: 1710402
[TBL] [Abstract][Full Text] [Related]
22. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
Andrews C; Humphrey PA
Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
[TBL] [Abstract][Full Text] [Related]
23. ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinoma.
Johnson H; Zhou M; Osunkoya AO
Hum Pathol; 2013 Oct; 44(10):2241-6. PubMed ID: 23849895
[TBL] [Abstract][Full Text] [Related]
24. IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2.
Merz C; von Mässenhausen A; Queisser A; Vogel W; Andrén O; Kirfel J; Duensing S; Perner S; Nowak M
Am J Pathol; 2016 Apr; 186(4):974-84. PubMed ID: 27012192
[TBL] [Abstract][Full Text] [Related]
25. Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer.
Sabaliauskaite R; Jarmalaite S; Petroska D; Dasevicius D; Laurinavicius A; Jankevicius F; Lazutka JR
Genes Chromosomes Cancer; 2012 Aug; 51(8):781-91. PubMed ID: 22505341
[TBL] [Abstract][Full Text] [Related]
26. Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?
Erturk K; Tastekin D; Gundogdu G; Tas F; Vatansever S
Biomed Pharmacother; 2016 Feb; 77():27-9. PubMed ID: 26796261
[TBL] [Abstract][Full Text] [Related]
27. Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry.
Schelling LA; Williamson SR; Zhang S; Yao JL; Wang M; Huang J; Montironi R; Lopez-Beltran A; Emerson RE; Idrees MT; Osunkoya AO; Man YG; Maclennan GT; Baldridge LA; Compérat E; Cheng L
Hum Pathol; 2013 Oct; 44(10):2227-33. PubMed ID: 23850495
[TBL] [Abstract][Full Text] [Related]
28. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
29. Acute diplopia and a solitary lung mass: a unique presentation of light-chain myeloma.
Foresman BH; Friess G; Brown A; McIntosh W
J Am Osteopath Assoc; 1996 Jun; 96(6):371-2. PubMed ID: 8690628
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma.
Yu SC; Chen SU; Lu W; Liu TY; Lin CW
Histopathology; 2011 May; 58(6):896-905. PubMed ID: 21401705
[TBL] [Abstract][Full Text] [Related]
31. Gamma globulin studies of biospy material and serum in solitary plasmacytoma of the spine.
Nerenberg ST
Cancer; 1969 Oct; 24(4):750-7. PubMed ID: 4186112
[No Abstract] [Full Text] [Related]
32. Immunoreactive cytokeratins in plasmacytomas.
Wotherspoon AC; Norton AJ; Isaacson PG
Histopathology; 1989 Feb; 14(2):141-50. PubMed ID: 2468596
[TBL] [Abstract][Full Text] [Related]
33. Intrasellar solitary plasmacytoma terminating in multiple myeloma: a report of a case including electron microscopical study.
Urbanski SJ; Bilbao JM; Horvath E; Kovacs K; So W; Ward JV
Surg Neurol; 1980 Sep; 14(3):233-6. PubMed ID: 7001658
[TBL] [Abstract][Full Text] [Related]
34. ERG expression in prostate cancer: the prognostic paradox.
Taris M; Irani J; Blanchet P; Multigner L; Cathelineau X; Fromont G
Prostate; 2014 Nov; 74(15):1481-7. PubMed ID: 25175352
[TBL] [Abstract][Full Text] [Related]
35. Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.
Kimura T; Furusato B; Miki J; Yamamoto T; Hayashi N; Takahashi H; Kamata Y; van Leenders GJ; Visakorpi T; Egawa S
Pathol Int; 2012 Nov; 62(11):742-8. PubMed ID: 23121605
[TBL] [Abstract][Full Text] [Related]
36. ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer.
Berg KD; Brasso K; Thomsen FB; Røder MA; Holten-Rossing H; Toft BG; Iversen P; Vainer B
J Clin Pathol; 2015 Oct; 68(10):788-94. PubMed ID: 26060265
[TBL] [Abstract][Full Text] [Related]
37. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
[TBL] [Abstract][Full Text] [Related]
38. [Clinico-pathology of skull tumor: Ewing's sarcoma, malignant lymphoma, plasmacytoma/multiple myeloma].
Kawamoto K; Numa Y; Imahori T; Kato T; Yamada A; Nakashima Y
No Shinkei Geka; 2004 Jun; 32(6):669-76. PubMed ID: 15352637
[No Abstract] [Full Text] [Related]
39. Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates.
Väänänen RM; Ochoa NT; Boström PJ; Taimen P; Pettersson K
BMC Urol; 2015 Aug; 15():88. PubMed ID: 26294063
[TBL] [Abstract][Full Text] [Related]
40. ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis.
Gao X; Li LY; Zhou FJ; Xie KJ; Shao CK; Su ZL; Sun QP; Chen MK; Pang J; Zhou XF; Qiu JG; Wen XQ; Yang M; Bai XZ; Zhang H; Ling L; Chen Z
Clin Cancer Res; 2012 Aug; 18(15):4163-72. PubMed ID: 22696228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
